The bovine coronavirus (BCV) spike glycoprotein precursor (S, formerly termed peplomer) and its two subunit polypeptides (Sl and S2) were individually expressed in Spodoprera frugiperda (Sf9) insect cells. Each recombinant baculovirus expressed both glycosylated (S, 170K; Sl, 95K; S2, 80K) and unglycosylated (S,, 140K; Sl,, 75K; and S20, 85K) forms of BCV spike polypeptides in Sf9 cells. The mature 95K Sl polypeptide was secreted whereas the S and S2 polypeptides remained cell-associated. The S precursor was partially cleaved in 39 cells, and the resulting Sl was also released into the medium. Neutralizing monoclonal antibodies representing two antigenic domains bound to recombinant S and Sl but not the S2 polvpeotides. indicating that two major epitopes for BCV neutralization are located on _.
INTRODUCTION
Bovine coronavirus (BCV) is an enteropathogenic coronavirus causing severe diarrhea in newborn calves. BCV contains four major structural proteins: the nucleocapsid protein (N; 50K-54K), the matrix protein (M; 23K-26K), the hemagglutinin/esterase (HE; 124K), and the spike protein (S; 180K) (King and Brian, 1982; Deregt et a/., 1987; Cry-Coats et a/., 1988) . The HE glycoprotein is a disulfide-linked dimer, which can be reduced to two identical subunits of 60K polypeptide, and exhibits hemagglutinating and receptor-destroying activities (Vlasak et al., 1988a,b; Parker et al., 1990b; Kienzie et a/., 1990) .
The S glycoprotein forms large surface projections characteristic of coronaviruses (Spaan et a/., 1988). The S polypeptide is 1363 amino acids long, as deduced from the BCV S nucleotide sequence, and exhibits a typical class I glycoprotein profile with a N-terminal signal sequence and a transmembrane sequence near the C-terminal end (Parker et a/., 1990a). Amino acid sequence comparison of the BCV S glycoprotein revealed a sequence homology to murine hepatitis coronavirus (MHV) strains JHM and A-59 with a notable difference of a 49 and 138 amino acid insertion in the Sl region, respectively (Schmidt et a/,, 1987 , Luytjes et a/., 1987 Parker et al. 1990a) . Proteolytic cleavage of the S glycoprotein yields two subunit proteins; the N-terminal half as the Sl subunit and the C-terminal half as the S2 subunit (Spaan et a /., 1988) . Cleavage of the coronavirus S precursor is a prerequisite for the ' To whom requests for reprints should be addressed. fusion activity (Storz et al., 1981; Sturman et al., 1985) . Similar to other coronaviruses, cleavage of the BCV S glycoprotein is predicted to occur at the sequence RR-SRR in positions 764-768 (Parker et a/., 1990a).
The S glycoprotein functions in virus attachment to permissive cells (Collins et al., 1982; Cavanagh and Davis, 1986) , cell fusion (Storz et a/., 1981; Sturman et al., 1985; Yoo et al., manuscript in preparation) , and induction of neutralizing antibodies (Cavanagh et al., 1988; Spaan et a/., 1988) . For avian infectious bronchitis virus (IBV), the most relevant region for interaction with and induction of neutralizing antibodies are found near the N-terminus of the Sl subunit (Cavanagh et al., 1988) . In contrast, for MHV, the S2 subunit has been reported to contain neutralizing epitopes (Makino et al., 1987; Talbot et al., 1988; Luytjes et al., 1989) . Two nonoverlapping groups of monoclonal antibodies (A and B) have been identified which interact with the BCV S glycoprotein (Deregt and Babiuk, 1987) . These monoclonal antibodies neutralize BCV infectivity in vivo (Deregt et al., 198913) and in vitro (Deregt and Babiuk, 1987) . However, the location of the neutralizing epitopes on the BCV S glycoprotein have not yet been determined.
Recently, the baculovirus Autographa californica (AcMNPV) has been widely used as an helper-independent expression vector for high level foreign gene expression. Recombinant proteins appear to undergo proper post-translational modification and transport in insect cells (Luckow and Summers, 1988; Miller, 1988; Cameron et a/., 1989) . We have introduced the peplomeric glycoprotein gene of BCV into the baculovirus genome. In this paper we report the characteriza-AND BABIUK tion of the recombinant BCV peplomeric polypeptides produced in Sf9 cells, and demonstrate that the major neutralizing epitopes are located on the Sl subunit.
MATERIALS AND METHODS

Cells and viruses
S. frugiperda cells (Sf9, ATCC CRL 1711) were grown in suspension in TNM-FH medium containing 50 pg/ml of gentamycin supplemented with 10% fetal bovine serum (GIBCO) at 28" (Summers and Smith, 1987) . The E2 strain of A. californica (AcMNPV) and the recombinant baculoviruses were propagated and titrated on a monolayer of Sf9 cells.
Cloning of recombinant plasmids
Restriction enzymes and DNA modifying enzymes were purchased from Pharmacia. Figure 1 illustrates the primary structure of the recombinant spike proteins of BCV. The cloned S gene of BCV (Quebec strain) was obtained from plasmid pCVE2 (Parker er al., 1990a) . For cloning of the Sl-coding sequence, pCVE2 was digested with Tthl 11 I, which cleaved nucleotides 2294-2295 within the sequences encoding a putative proteolytic cleavage site of the S protein precursor, and asymmetric ends were blunted by Klenow fill-in reaction followed by digestion with BarnHI. The 2.3-kb fragment was purified and ligated into the BarnHI and blunt-endedXba I sites of the pTZl8R. A universal translation termination sequence (5'-GCTTAATTAATTAAGC-3') was subsequently inserted at the Hincll site of the polylinker region and the resulting plasmid was termed pCVS1. pCVS1 was digested with Sphl and repaired with T, DNA polymerase. A BarnHI linker was then attached to the blunted Sphl end followed by subsequent BarnHI digestion and ligation into the BarnHI site of the baculovirus transfer vector pAcYM 1 (Matsuura er a/., 1987; a gift from Dr. C. Y. Kang, University of Ottawa, Canada). Construction of the S2 gene will be described elsewhere. Briefly, a Sphl-Sty1 fragment of pCVE3 (Parker et a/., 1989a) was fused to a Seal-Sphl fragment from pCVE2 so that the resulting clone contained the entire S2-coding sequence proceeded by the sequence encoding 16 amino acids of the HE membrane translocational signal.
Antisera
Anti-BCV polyclonal rabbit sera and the BCV S-specific monoclonal antibodies were used as mouse ascitic fluids. Production and properties of the S-specific monoclonal antibodies, BB7-14, HF8-8, JB5-6, and HE7-3, have been previously described (Deregt and Babiuk, 1987) .
Construction of recombinant viruses
A monolayer of S. frugiperda cells (1.2 X 1 O6 cells per 35-mm dish) was transfected with a mixture of 1 pg of AcMNPV genomic DNA and 2-4 pg of plasmid DNA in 20 m/l/l Hepes, pH 7.05,l mM Na,HPO,, 5 mNI KCI, 150 mM NaCI, and 100 mM glucose. Prior to inoculation, the above mixture was precipitated by incubation with CaCI, (final concentration 125 mn/l) at room temperature for 30 min. The transfection mix was removed after 1 hr and the cells were then further incubated with 2 ml of fresh medium. The supernatant was harvested after 4 days, and recombinant viruses were screened by plaque hybridization followed by several rounds of plaque purification (Summers and Smith, 1987) . Construction of the recombinant baculoviruses containing the S precursor and S2 subunit genes (termed pAcS and pAcS2, respectively) are described in detail elsewhere (Parker er al., 1990a; Yoo et al., manuscript in preparation) .
Infection and protein analysis
Sf9 cells, at a density of 2 X lo6 cells per 35-mm dish, were infected with baculoviruses at a m.o.i. of 10 to 20. The inoculum was removed after 1 hr adsorption and replaced with TNM-FH for further incubation. For in viva radiolabeling, the medium was replaced with methionine-free Grace's medium for 1 hr. A total of 120 &i/ml of [35S]methionine (800 Ci/mmol, Amersham) was added and the cells were incubated for 4 hr. For pulse-chase studies, the cells were radiolabeled for 30 min, followed by addition of methionine-enriched TNM-FH for the indicated chase times. The cells were then Cell lysates were prepared and immunoprecipitated using anti-BCV polyclonal rabbit sera and resolved by 7.5% SDS-PAGE. Lanes: 1, 14Clabeled protein mol wt marker; 2, BCV proteins (Sl , S2, HE, N, and M); 3 and 7, wild-type AcNPV-infected cell lysates; 4 and 8, vAcSinfected cell lysates; 5 and 9, vAcS1 -infected cell lysates; 6 and 10, vAcS2-infected cell lysates.
washed with cold phosphate-buffered solution and lysed with 200 ~1 of RIPA buffer (1% Triton X-l 00, 1% sodium deoxycholate, 150 mM NaCI, 50 mMTris-HCI, pH 7.4, 10 mM EDTA, 0.1% SDS). For the radioimmunoprecipitation, 1 ~1 of the appropriate antibody was incubated with a suspension of 10 mg protein A-Sepharose CL-4B beads (Pharmacia). The beads were washed three times with RIPA buffer and 20 ~1 of cell lysate was added to the beads for further incubation. The immune complexes were dissociated with sample buffer (10% SDS, 25% glycerol, 10% 2-mercaptoethanol, 10 mMTris-HCI, pH 6.8,0.02% bromphenol blue) and subjected to electrophoresis on a 7.5% discontinuous SDS-polyacrylamide gel followed by autoradiography.
RESULTS
Synthesis of the S, Sl , and S2 polypeptides in Sf9 ceils
The synthesis of the BCV S polypeptides in insect cells infected with recombinant baculoviruses was measured by immunoprecipitation at 24 and 48 hr postinfection ( Fig. 2A) . Polypeptides of 170K (lane 4) 95K (lane 5) and 80K (lane 6) were produced 24 hr postinfection from the cells infected with vAcS, vAcS1, and vAcS2 recombinants, respectively. The 170K polypeptide in vAcS-infected cells was similar in migration rate to the uncleaved S precursor protein found in BCVinfected MDBK cells (Deregt eta/., 1987) . The 95K and 80K polypeptides from the cells infected with vAcS1 and vAcS2 represented the St and S2 polypeptides, respectively. The recombinant Sl and S2 polypeptides were smaller in molecular weight than those of 1 OOK and 95K found in the S2 polypeptides were smaller in molecular weight than those of 1 OOK and 95K found in the BCV virion ( Fig. 2A, lane 2) .
When the vAcS-infected cell lysate was analyzed 48 hr postinfection (Fig. 2B ), in addition to the 170K polypeptide a 140K polypeptide (S,) was immunoprecipitated (lane 8). Cells infected with vAcS1 and vAcS2 also produced two forms of recombinant polypeptides at 48 hr postinfection (Fig. 2B , lanes 9 and 10); the 95K (Sl) and 75K (Sl,) polypeptides and the 80K (S2) and 65K (S2,) polypeptides, respectively.
In order to determine if the 140K, 75K, and 65K bands represented nonglycosylated forms of the corresponding mature polypeptide, tunicamycin treatment was carried out. Tunicamycin, an inhibitor of N-linked glycosylation, has been demonstrated to be effective in insect cells (Charlton and Volkman, 1986) . ThevAcSinfected cells were radiolabeled at 24 postinfection in the presence of various concentrations of tunicamycin. Only the 170K polypeptide is synthesized at this time of infection in the absence of tunicamycin as shown in Fig. 3A (lane 3) . Tunicamycin at 15 wg/ml inhibited the production of the 170K polypeptide and only the 140K polypeptide was detected (Fig. 38, lane 4) . This result suggested that the 140K polypeptide was the nonglycosylated immature form of the mature 170K S polypeptide. Similar results were obtained with vAcS1 (Fig.  3C , lane 3) and vAcS2 (Fig. 3D , lane 6) demonstrating that the 75K and 65K polypeptides were the nonglycosylated Sl and S2 polypeptides, respectively. Molecular weights of the nonglycosylated S, Sl , and S2 polypeptides are consistent with those of predicted polypeptides deduced from the nucleotide sequences (Parker et al., 1990a) . Cleavage of the S glycoprotein precursor in vAcS-infected cells was not detected either in the absence or presence of tunicamycin.
Neutralizing epitopes of the Sl subunit
Two antigenic domains responsible for BCV neutralization have been identified on the BCV S protein (Deregt and Babiuk, 1987) . In order to approximate the location of these domains, the cell lysates prepared with vAcS1 or vAcS2 were reacted with monoclonal antibodies specific for each domain. The S ( the polyclonal antibody did (Fig. 48, lane 5) . These results indicate that two major neutralizing epitopes of BCVare located on the Sl subunit. The unglycosylated S and St polypeptides were also bound by these monoclonal antibodies (Figs. 4A and 4C ), suggesting that monoclonal antibodies HE7-3, Ji35-6, HF8-8, and BB7-14 were all glycosylation-independent.
Furthermore, these results also indicate that the recombinant S and Sl polypeptides produced in Sf9 cells assume the proper conformation in the vicinity of these epitopes, since these m~noclonal antibodies have been shown to recognize conformation-dependent epitopes (Deregt and Babiuk, 1987) .
Secretion of the Sl subunit and partial cleavage of the S polypeptide
Since the Sl subunit has been found to contain major BCV neutralizing epitopes and because the sequences encoding the Sl subunit have been constructed to retain a membrane translo~at~on signal, but not a membrane anchor, we were interested in the ceflular transport of the S1 polypept~de in insect cells. In order to determine if the Sl pofypeptide was secreted, cell culture supernatants were immunoprecipitated with Sl -specific monoclonal antibodies and analyzed by SDS-PAGE. Cell labeling was done early in the infection period (20 hr p.i.) prior to the appearance of cytopathology. As shown in Fig. 5 , a 9OK polypeptide was released into the culture medium (lanes 3 and 5) and had a slightly faster migration rate than the 9% intracellutar counterpa~ (lanes 8 and 10) . The decrease in the size of the 90K polypeptide was probably due to the further processing of the Sl potypeptide during the extracellular transport. When the culture medium from cells infected with VACS was examined, the uncleaved S precursor polypeptide was not detected (lane Z), confirming that the presence of the Sl in the culture medium was not due to cell destruction. Previously, the recombinant S polypeptide was shown to be associ- At 20 hr postinfection, the medium was replaced with 800 ~1 of methionine-free Grace's medium containing 800 &i/ml of [%I methionine (800 Ci/mmol, Amersham), and the cells were further incubated.
After 12 hr incubation, the culture media was harvested and the cell debris were clarified two times by centrifugation at 14,000 rpm for 5 mrn In a microcentrifuge.
The supernatants were then subjected to immunoprecipitation with a pool of the Sl-specific group A monoclonal antibodies.
The corresponding cell lysates were also prepared and analyzed by immunoprecipitation. (A) extracellular culture media; (B) intracellular lysates corresponding to the lanes in A; lanes: 1 and 6, wild-type AcNPV; 2 and 7, vAcS; 3 and 8, vAcS1; 4 and 9, vAcS2; 5 and 10. co-infection of vAcS1 andvAcS2.
ated with the plasma membrane of Sf9 cells (Parker et a/., 1990a). In addition, the Sl -specific antibodies also precipitated a 90K polypeptide from the media of vAcSinfected cells (lane 2). This observation indicates that the S precursor is partially cleaved in Sf9 cells and the resulting Sl subunit is released to the medium. Taken together, all of these findings indicate that the signal sequence of the BCV S polypeptide is efficiently recognized in insect cells, and the Sl polypeptide is posttranslationally processed and transported through the secretory pathway. Since the cells were labeled at an early stage of infection, neither the nonglycosylated S nor S 1 were detected in the cells. In order to evaluate the kinetics of Sl secretion, pulse-chase experiments were performed. To examine whether the unglycosylated Sl was also secreted, labeling was carried out at 36 hr postinfection, at which time both glycosylated and unglycosylated forms were present. The cells were labeled for 30 min and chased for up to 60 hr postinfection. The secretion of the Sl polypeptide increased as a function of time up to 7 hr. After 7 hr, there was no apparent increase in the amount of secreted polypeptides (Fig. 6A) . In vAcS-infected cells, the 90K polypeptide was again identified in extracellular fluids with a secretion rate similar to that in vAcSl-infected cells (Fig. 6B ). This result confirms partial cleavage of the S precursor and release of the Sl subunit. Nonglycosylated Sl was not detected extracellularly in either case despite the presence of both glycosylated and nonglycosylated forms of the Sl and S polypeptides in intracellular fractions (Fig. 6C) . No apparent changes were observed in the intracellular amounts of glycosylated or unglycosylated Sl as a function of chase time (Fig. 6C ).
DISCUSSION
The S peplomeric precursor of BCV and its two subunit glycoproteins were expressed in Sf9 cells using a recombinant baculovirus vector. The Sl subunit coding sequence contained the entire upstream sequence, including the membrane translocation signal, from the putative cleavage site of the S precursor. Since the S2 coding sequence includes a membrane anchor but lacks a membrane translocational signal, the BCV HE signal sequence was attached to the Nterminus of the S2 gene (Fig. 1) . All of the recombinant S, Sl , and S2 polypeptides were glycosylated and immunoreactive with anti-BCV polyclonal antisera. Nonglycosylated forms were also detected at 36 hr postinfection. The lack of glycosylation at later stages of baculovirus infection may be due to the saturation of the surface of rough endoplasmic reticulum by polyribosomes, the depletion of the AI-glycosyl transferase, and/or other effects of baculovirus infection.
Molecular weights of the recombinant Sl and S2 polypeptides were estimated to be 95K and 80K, respectively, while the polypeptides produced in BCV-infected mammalian cells generally comigrate as 1 OOK-1 1 OK (King and Brian, 1982; Deregt eta/., 1987) . Insect cells have been reported to be incapable of processing complex type oligosaccharides in IV-glycosylation, and to convert high mannose-type oligosaccharides to trimannosyl cores (Hsieh and Robbins, 1984) . Recently accumulating information has indicated that the glycosylation of baculovirus-produced recombinant proteins is somewhat different from that of the proteins produced in mammalian cells (Miller, 1988; Cameron et a/., 1989; Jarvis and Summers, 1989) . Although we cannot rule out the possibility of internal or terminal deletions in the polypeptide sequences produced in insect cells, it seems likely that the molecular weight differences of the authentic versus recombinant Sl and S2 are due to the differences in the nature of glycosylation (Fig. 2) . Attempts to directly compare the nonglycosylated-recombinant Sl and S2 with the tunicamycin-treated authentic Sl and S2 were unsuccessful.
Secretion of the Sl polypeptide confirmed that the signal sequences of BCV S and BCV HE glycoproteins were efficiently recognized in Sf9 cells, and directed membrane translocation and subsequent cellular transport. The recombinant Sl polypeptide was secreted into the culture medium from the cells, while the S precursor and the S2 subunit remained associated with the plasma membrane (Parker eta/,, 1990a). Even though both glycosylated and unglycosylated Sl polypeptides were present in the cells, only the glycosylated form was secreted (Fig. 6) . Similarly, Jarvis and Summers (1989) observed that only glycosylated human tPA was secreted. It has also been shown that secretion of vitellogenin was inhibited in Sf9 cells by tunicamycin treatment (Wojchowski eta/., 1986) . Thus, these observations suggest that the N-glycosylation of the recombinant Sl polypeptide is required for the transport through the secretory pathway in Sf9 cells.
Secretion of the Sl polypeptide was somewhat slower and inefficient in Sf9 cells compared to secretion in mammalian cells. Similar results have been observed for tPA secretion (Jarvis and Summers, 1989) . In contrast, the truncated form of the F glycoprotein of respiratory syncytial virus (RSV) was efficiently secreted in Sf9 cells (Wathen et al., 1989) . It has been shown with two different viral glycoproteins (influenza hemagglutinin and vesicular stomatitis virus G protein) that folding and assembly of native structures are essential for their transport and subsequent maturation through the exocytotic pathway in mammalian cells (Gething et a/., 1986; Kreis and Lodish, 1986 ). Therefore, it is possible that the unusually high content of cysteine residues in the Sl subunit of BCV (36 residues) may alter the proper folding of the polypeptide synthesized in Sf9 cells, which becomes a limiting fac-tor for efficient secretion (also refer to Pennica et a/., 1983; tPA has 35 cysteine residues).
The extracellular form of the Sl polypeptide was slightly smaller by approximately 5K than the intracellular counterpart, as previously noted with a secreted form of the BCV HE polypeptide (Parker et a/., 1990b) . It remains to be determined whether the difference in the size of the two forms are related to the primary structure of the polypeptide (i.e., cleavage of the signal peptide) or further modification of the oligosaccharides during or after the extracellular transport.
Cleavage of the BCV S precursor in Sf9 cells did not occur to a significant extent. Although the Sl polypeptide was detected in the vAcS-infected cell culture medium, the predominant form was the uncleaved S precursor. We were unable to detect the S2 portion of the cleaved S precursor, probably due to the limited amounts of cleaved products and the lack of monoclonal antibodies specific for the S2 subunit. However, cell fusion was observed in the vAcS-infected Sf9 cells, confirming the cleavage of the S precursor and the presence of the S2 subunit as a cleaved product (Yoo et a/., manuscript in preparation) . It is noteworthy that the cleavage of the recombinant S has not been previously observed in either IBV peplomer expression in vaccinia virus (Tomley et a/., 1987) or MHV-JHM peplomer expression in baculovirus (Yoden et al., 1989) .
Cleavage of the S peplomer appears to be important in coronavirus pathogenesis. Cell fusion is activated by proteolytic cleavage of the S protein (Sturman et al., 1985; Yoo et a/., manuscript in preparation) . In MHV and IBV, it has been demonstrated that the S protein is , 1982; Cavanagh and Davis, 1986) . While it is not clear whether the S protein of BCV also plays a role for the cell binding, it will be of interest to determine if proteolytic cleavage is related to the cell binding activity of the S protein.
Most of the critical epitopes for neutralization in transmissible gastroenteritis virus (TGE) (Jimknez et a/., 1986), IBV (Cavanagh eta/., 1988), and MHV (Talbot et a/., 1984) appear to be conformation-dependent.
The S glycoprotein of BCV also contains at least two major conformation-dependent neutralizing epitopes, which are located on the Sl subunit as shown in Fig. 4 . During the preparation of this manuscript, Parker et al. (1989b) reported that wild-type MHV-4 contained an additional 142 to 159 amino acids in the Sl region when compared to that of neutralization-resistant, neuroattenuated MHV-4 variants. This polymorphic domain present in wild-type MHV-4 was suggested to be responsible for the neutralization and pathogenesis in MHV (Parker et a/., 198913) . A similar situation may exist in the S protein of BCV. Amino acids 456-593 of the BCV Sl subunit were previously thought to be BCV unique by comparison to the Sl sequences of MHV strains JHM and A-59 (Parker et al., 1990a) . However, significant sequence homology was observed when this region of the BCV Sl subunit was compared to that of polymorphic domain of wild-type MHV-4 ( Fig. 7) . Interestingly, all 16 cysteine residues present in this region of BCV were perfectly conserved in the polymorphic domain of wild-type MHV-4 ( Fig. 7) . This suggests that the region of amino acids 456-593 of the BCV Sl subunit may possess functions similar to the polymorphic domain of the wild-type MHV-4 S protein. Deregt et al. (1989a) have tentatively identified a 37K trypsin fragment from the S polypeptide that contains both BCV neutralizing epitopes. The 37K fragment lies upstream to the putative S cleavage site, and partly over-laps with this same region. When we expressed a truncated form of the BCV S 1 which extended to the middle (amino acids l-51 6) of this region, the polypeptide produced did not react with any of the monoclonal antibodies (unpublished observation).
All of these observations imply that amino acids 456-593 of the BCV Sl subunit may be associated with antigenic determinants for both groups of neutralizing antibodies. We have generated several mutants resistant to Sl-specific monoclonal antibodies (mar) and are currently determining the sequence of the Sl subunit of these mar mutants. This will provide valuable information for identifying the neutralizing epitopes and pathogenesis in BCV. (1982) . Monoclonal antibodies to munne hepatitis virus 4 (strain
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